← All investors
Eventide
12 portfolio companies · 2 on the map · $2.6B raised · 2 cities
Portfolio map
2 Eventide portfolio companies on the map.
Portfolio companies
Praxis Precision Medicines
Boston
The era of genetic neuroscience has arrived
Biotechnology Research$1.7BEst. 2015
Zentalis
San Diego
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
Biotechnology Research$896.6M
More portfolio companies
9 more Eventide investments we track beyond the map — 12 tracked in total.
BBOTPalo Alto · Post-IPO Equity
Flare TherapeuticsCambridge · Series B
PreciseDxNew York · Series B
Inventiva PharmaDaix · Post-IPO Equity
Pliant TherapeuticsSouth San Francisco · Series C
Ovid TherapeuticsNew York · Post-IPO Equity
Karuna TherapeuticsBoston · Series B
VYNE TherapeuticsMenlo Park · Post-IPO Equity
Entasis TherapeuticsWaltham · Series B
Portfolio map
2 Eventide portfolio companies on the map.